MVP Stock Overview
Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Medical Developments International Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.42 |
52 Week High | AU$1.08 |
52 Week Low | AU$0.38 |
Beta | 1.53 |
11 Month Change | -10.64% |
3 Month Change | -8.70% |
1 Year Change | -46.67% |
33 Year Change | -91.33% |
5 Year Change | -93.86% |
Change since IPO | -65.57% |
Recent News & Updates
Recent updates
Shareholder Returns
MVP | AU Pharmaceuticals | AU Market | |
---|---|---|---|
7D | -3.4% | -16.4% | 0.9% |
1Y | -46.7% | 32.3% | 18.4% |
Return vs Industry: MVP underperformed the Australian Pharmaceuticals industry which returned 32.2% over the past year.
Return vs Market: MVP underperformed the Australian Market which returned 18.4% over the past year.
Price Volatility
MVP volatility | |
---|---|
MVP Average Weekly Movement | 5.3% |
Pharmaceuticals Industry Average Movement | 11.9% |
Market Average Movement | 8.5% |
10% most volatile stocks in AU Market | 17.5% |
10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: MVP has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: MVP's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1972 | n/a | Brent MacGregor | medicaldev.com |
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures.
Medical Developments International Limited Fundamentals Summary
MVP fundamental statistics | |
---|---|
Market cap | AU$47.32m |
Earnings (TTM) | -AU$40.99m |
Revenue (TTM) | AU$33.15m |
1.4x
P/S Ratio-1.2x
P/E RatioIs MVP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MVP income statement (TTM) | |
---|---|
Revenue | AU$33.15m |
Cost of Revenue | AU$8.78m |
Gross Profit | AU$24.37m |
Other Expenses | AU$65.36m |
Earnings | -AU$40.99m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.36 |
Gross Margin | 73.50% |
Net Profit Margin | -123.66% |
Debt/Equity Ratio | 0% |
How did MVP perform over the long term?
See historical performance and comparison